DNA methylation as a predictor of mepolizumab response in asthma

Koppelman, G. (Speaker)

Groningen Research Institute for Asthma and COPD (GRIAC)

Activity: Talk and presentation › Professional or public presentation › Professional

Description

1 hour online presentation to GSK genetics (USA), followed by a round table discussion with GSK leadership on genetics and anti-IL5 clinical development

Period	30-Apr-2021
Held at	Glaxo Smith Kline, United States
Degree of Recognition	International